Desk Business
The probe, which may cause a delay in the dental products maker’s quarterly filing with U.S. securities regulators, was focused on the use of incentives to sell products to distributors and whether those were properly accounted.
Moderna Inc’s CFO, Jorge Gomez, left a day after taking charge, the vaccine maker said on Wednesday, following his previous employer unveiling an internal probe connected to financial reporting. Gomez’s appointment was declared in April and he accepted charge on Monday. Moderna said he left on Tuesday after Dentsply Sirona Inc declared the investigation. Dentsply last month fired its then-CEO Don Casey without uncovering a reason.
Suggestion For You:
Gomez was not immediately available for comment when contacted on LinkedIn, while Moderna did not have additional comments beyond the press release and the filing.
Moderna said recently retired finance chief David Meline will return, as the company reopens its search for a new CFO.
“It’s tough optics for Moderna. They spent a lot of time and effort hiring the new CFO. However, it seems the problem was at the previous company, and should have no impact on Moderna,” said Oppenheimer & Co analyst Hartaj Singh.
Gomez will receive 12 months’ salary, totaling $700,000, and forfeit his signing bonus and bonus eligibility, the vaccine maker said.
Moderna’s shares fell 1% to $130.98 in early trading.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week
Russia will not participate in the UN Human Rights Council’s special session on Ukraine
iMessage and FaceTime are not working due to a iPhone problem
In June, Warhammer Skulls will release fresh information on Space Marine 2
Bill Gates Uses Samsung Galaxy Z Fold 3, Not Microsoft’s Surface Duo 2
To reduce inequality, governments must act quickly
1K Kirana raises $25 million, targets to serve over 10 million consumers in 1 year
Foxconn Zhengzhou factory started contracting for the iPhone 14 production line
In Davos, industry and government executives warn that the economic picture ‘has darkened’
Mandaviya expresses concern about WHO study of excessive COVID mortality in India at world summit
